These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

540 related articles for article (PubMed ID: 33526777)

  • 1. Role of lysophosphatidic acid and its receptors in health and disease: novel therapeutic strategies.
    Geraldo LHM; Spohr TCLS; Amaral RFD; Fonseca ACCD; Garcia C; Mendes FA; Freitas C; dosSantos MF; Lima FRS
    Signal Transduct Target Ther; 2021 Feb; 6(1):45. PubMed ID: 33526777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autotaxin⁻Lysophosphatidic Acid Signaling in Alzheimer's Disease.
    Ramesh S; Govindarajulu M; Suppiramaniam V; Moore T; Dhanasekaran M
    Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29933579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of lysophosphatidic acid pathway modulators as therapies for fibrosis.
    Budd DC; Qian Y
    Future Med Chem; 2013 Oct; 5(16):1935-52. PubMed ID: 24175745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic potential of autotaxin/lysophospholipase d inhibitors.
    Federico L; Pamuklar Z; Smyth SS; Morris AJ
    Curr Drug Targets; 2008 Aug; 9(8):698-708. PubMed ID: 18691016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological roles of lysophosphatidic acid signaling through its production by autotaxin.
    Okudaira S; Yukiura H; Aoki J
    Biochimie; 2010 Jun; 92(6):698-706. PubMed ID: 20417246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The autotaxin-lysophosphatidic acid-lysophosphatidic acid receptor cascade: proposal of a novel potential therapeutic target for treating glioblastoma multiforme.
    Tabuchi S
    Lipids Health Dis; 2015 Jun; 14():56. PubMed ID: 26084470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlling cancer through the autotaxin-lysophosphatidic acid receptor axis.
    Gotoh M; Fujiwara Y; Yue J; Liu J; Lee S; Fells J; Uchiyama A; Murakami-Murofushi K; Kennel S; Wall J; Patil R; Gupte R; Balazs L; Miller DD; Tigyi GJ
    Biochem Soc Trans; 2012 Feb; 40(1):31-6. PubMed ID: 22260662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of tumor cell - Microenvironment interaction by the autotaxin-lysophosphatidic acid receptor axis.
    Tigyi GJ; Yue J; Norman DD; Szabo E; Balogh A; Balazs L; Zhao G; Lee SC
    Adv Biol Regul; 2019 Jan; 71():183-193. PubMed ID: 30243984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autotaxin and LPA receptor signaling in cancer.
    Houben AJ; Moolenaar WH
    Cancer Metastasis Rev; 2011 Dec; 30(3-4):557-65. PubMed ID: 22002750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of extracellular lysophosphatidic acid in the regulation of adipocyte functions and liver fibrosis.
    Yang F; Chen GX
    World J Gastroenterol; 2018 Sep; 24(36):4132-4151. PubMed ID: 30271079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autotaxin Regulates Maintenance of Ovarian Cancer Stem Cells through Lysophosphatidic Acid-Mediated Autocrine Mechanism.
    Seo EJ; Kwon YW; Jang IH; Kim DK; Lee SI; Choi EJ; Kim KH; Suh DS; Lee JH; Choi KU; Lee JW; Mok HJ; Kim KP; Matsumoto H; Aoki J; Kim JH
    Stem Cells; 2016 Mar; 34(3):551-64. PubMed ID: 26800320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Autotaxin-Lysophosphatidic Acid Axis Promotes Lung Carcinogenesis.
    Magkrioti C; Oikonomou N; Kaffe E; Mouratis MA; Xylourgidis N; Barbayianni I; Megadoukas P; Harokopos V; Valavanis C; Chun J; Kosma A; Stathopoulos GT; Bouros E; Bouros D; Syrigos K; Aidinis V
    Cancer Res; 2018 Jul; 78(13):3634-3644. PubMed ID: 29724718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysophosphatidic acid production and action: critical new players in breast cancer initiation and progression.
    Panupinthu N; Lee HY; Mills GB
    Br J Cancer; 2010 Mar; 102(6):941-6. PubMed ID: 20234370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The critical role and potential target of the autotaxin/lysophosphatidate axis in pancreatic cancer.
    Quan M; Cui JJ; Feng X; Huang Q
    Tumour Biol; 2017 Mar; 39(3):1010428317694544. PubMed ID: 28347252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of lysophosphatidic acid and its receptors in the kidney.
    Park F; Miller DD
    Physiol Genomics; 2017 Nov; 49(11):659-666. PubMed ID: 28939644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autotaxin-Lysophosphatidic Acid: From Inflammation to Cancer Development.
    Valdés-Rives SA; González-Arenas A
    Mediators Inflamm; 2017; 2017():9173090. PubMed ID: 29430083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ADSCs and adipocytes are the main producers in the autotaxin-lysophosphatidic acid axis of breast cancer and healthy mammary tissue in vitro.
    Schmid R; Wolf K; Robering JW; Strauß S; Strissel PL; Strick R; Rübner M; Fasching PA; Horch RE; Kremer AE; Boos AM; Weigand A
    BMC Cancer; 2018 Dec; 18(1):1273. PubMed ID: 30567518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autotaxin-Lysophosphatidic Acid Axis Acts Downstream of Apoprotein B Lipoproteins in Endothelial Cells.
    Gibbs-Bar L; Tempelhof H; Ben-Hamo R; Ely Y; Brandis A; Hofi R; Almog G; Braun T; Feldmesser E; Efroni S; Yaniv K
    Arterioscler Thromb Vasc Biol; 2016 Oct; 36(10):2058-67. PubMed ID: 27562917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The autotaxin-lysophosphatidic acid pathway in pathogenesis of rheumatoid arthritis.
    Orosa B; García S; Conde C
    Eur J Pharmacol; 2015 Oct; 765():228-33. PubMed ID: 26297977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted deletion of LPA5 identifies novel roles for lysophosphatidic acid signaling in development of neuropathic pain.
    Lin ME; Rivera RR; Chun J
    J Biol Chem; 2012 May; 287(21):17608-17617. PubMed ID: 22461625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.